The measurement of nociceptive peptides for the assessment of acute and chronic pain in the medicolegal investigation of violent death.

Item

Title
The measurement of nociceptive peptides for the assessment of acute and chronic pain in the medicolegal investigation of violent death.
Identifier
AAI9969721
identifier
9969721
Creator
Quarino, Lawrence A.
Contributor
Adviser: Peter De Forest
Date
2000
Language
English
Publisher
City University of New York.
Subject
Sociology, Criminology and Penology | Biology, Neuroscience
Abstract
Often during the sentencing phase of a homicide trial, juries are asked to determine the allocation of punitive damages and if aggravating factors exist. Very often, these determinations are made on a subjective assessment of the amount of pain inflicted upon a victim. The current study was designed to provide objective and qualitative criteria for these tasks by quantitatively measuring nociceptive peptides in post-mortem serum and brain tissue.;Three peptides (substance P, bradykinin, and met-enkephalin) were chosen for quantitative measurement by radioimmunoassay. These three peptides were chosen because of central but varied roles in the transmission and modulation of nociception.;Peptide levels differ in acutely and chronically painful death. Peptide levels indicative of acute pain and nociception are apparent in violent death when the incident-death interval is of short duration (minutes). Conversely, peptide levels reflective of chronic pain and antinociception become dominant in violent death when the incident-death time interval is large (months).;The mode of violent death affects peptide levels at certain incident-death time intervals. The variable that appears to affect the nociceptive response is the level of tissue damage typically associated with a particular mode of death. Those modes of death which tend to be characterized by extensive tissue trauma (i.e. thermal burns), show an accelerated nociceptive response.;Peptide levels in infant and child violent deaths do not differ from adult violent death values regardless of the incident-death time interval. Peptide levels in violent infant/child deaths, however, do significantly differ from those in SIDS and other clinical infant/child deaths.;Peptide levels in respective non-violent deaths differ due to the nature (acute and chronic) and extent of pain in each particular non-violent death. Ratios of nociceptive to antinociceptive serum and brain peptides in various non-violent deaths demonstrate the extent of pre-mortem acute and chronic pain in each type of death. By being able to equate the ratio of nociceptive to antinociceptive peptide levels in individuals who were violently killed with a particular type of non-violent clinical death, a qualitative and objective assessment can be made of the level of pain experienced by the victim. A clearer picture of the level of pain can be presented if peptide levels found in a victim of a violent death can, for with death due to renal disease, embolism, or cancer.
Type
dissertation
Source
PQT Legacy CUNY.xlsx
degree
Ph.D.
Item sets
CUNY Legacy ETDs